Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Barlow, William E  [Clear All Filters]
B
Billingsley, KG, Morris AM, Green P, Dominitz JA, Matthews B, Dobie SA, Barlow WE, Baldwin L-M.  2008.  Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection? Journal of the American College of Surgeons. 206(3):1167-77. Abstract
C
Chew, HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow JR, Hortobagyi GN, Livingston R.  2008.  A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5. Abstract
D
Dunnwald, LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF et al..  2008.  Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(27):4449-57. Abstract
H
Harigopal, M, Barlow WE, Tedeschi G, Porter PL, Yeh I-T, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C et al..  2010.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47. Abstract
J
Jackson, ML, Nelson JC, Weiss NS, Neuzil KM, Barlow WE, Jackson LA.  2008.  Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study.. Lancet. 372(9636):398-405. Abstract
Janes, H, Pepe MS, Bossuyt PM, Barlow WE.  2011.  Measuring the performance of markers for guiding treatment decisions.. Annals of internal medicine. 154(4):253-9. Abstract
M
Mehta, RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB et al..  2012.  Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44. Abstract
Morris, DE, Pepe MS, Barlow WE.  2010.  Contrasting two frameworks for ROC analysis of ordinal ratings.. Medical decision making : an international journal of the Society for Medical Decision Making. 30(4):484-98. Abstract
P
Phipps, AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'meara ES, Li CI.  2012.  Breast Density, Body Mass Index, and Risk of Tumor Marker-Defined Subtypes of Breast Cancer.. Annals of epidemiology. 22(5):340-348. Abstract
Phipps, AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI.  2011.  Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.. Breast cancer research and treatment. 126(3):671-8. Abstract
Phipps, AI, Li CI, Kerlikowske K, Barlow WE, Buist DSM.  2010.  Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(6):1643-54. Abstract
Phipps, AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI.  2011.  Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.. Cancer causes & control : CCC. 22(3):399-405. Abstract
R
Ramsey, SD, Barlow WE, Gonzalez-Angulo AM, Tunis S, Baker L, Crowley J, Deverka P, Veenstra D, Hortobagyi GN.  2012.  Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.. Contemporary clinical trials. 34(1):1-9. Abstract
T
Tubbs, R, Barlow WE, Budd TG, Swain E, Porter PL, Gown A, Yeh I-T, Sledge G, Shapiro C, Ingle J et al..  2009.  Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(24):3881-6. Abstract
W
Williams, LH, Shors AR, Barlow WE, Solomon C, White E.  2011.  Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.. Journal of clinical & experimental dermatology research. 2(6) Abstract
Wong, WB, Ramsey SD, Barlow WE, Garrison LP, Veenstra DL.  2012.  The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007).. Contemporary clinical trials. 33(6):1117-23. Abstract